A research team from Polytechnique Montréal, McGill University, and Université de Montréal has successfully developed novel nanorobotic agents that travel through the bloodstream and precisely inject a drug by targeting the active regions of cancerous tumors. The study represents a scientific breakthrough in cancer research.
This precise way of administering medication not only ensures the specific targeting of tumors, but also protects the integrity of organs and the adjacent healthy tissues. The intake of highly toxic drugs by human begins can be considerably reduced.
The study has been reported in the prestigious Nature Nanotechnology journal in an article titled “Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions.” The article describes the outcome of the study performed on mice, whose colorectal tumors were injected with nanorobotic agents.